Programmed Cell Death 4 and MicroRNA 21 Inverse Expression Is Maintained in Cells and Exosomes From Ovarian Serous Carcinoma Effusions

被引:112
|
作者
Cappellesso, Rocco [1 ]
Tinazzi, Andrea [1 ]
Giurici, Thomas [1 ]
Simonato, Francesca [1 ]
Guzzardo, Vincenza [1 ]
Ventura, Laura [2 ]
Crescenzi, Marika [3 ]
Chiarelli, Silvia [1 ]
Fassina, Ambrogio [1 ]
机构
[1] Univ Padua, Dept Med, Surg Pathol & Cytopathol Unit, I-35121 Padua, Italy
[2] Univ Padua, Dept Stat Sci, I-35121 Padua, Italy
[3] Ist Oncol Veneto IRCCS, Radiotherapy Unit, Padua, Italy
关键词
ovarian carcinoma; microRNA-21 (miR-21); programmed cell death 4 (PDCD4); exosomes; malignant effusions; NEOADJUVANT CHEMOTHERAPY; CANCER CELLS; TRANSFORMATION SUPPRESSOR; PRIMARY SURGERY; PDCD4; PROTEIN; IV; CHEMOSENSITIVITY; TRANSITION;
D O I
10.1002/cncy.21442
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: Ovarian serous carcinoma (OSC) is a fatal gynecologic malignancy usually presenting with bilateral localization and malignant peritoneal effusion. Programmed cell death 4 (PDCD4) is a tumor suppressor gene whose expression is directly controlled by microRNA-21 (miR-21). Exosomes are small cell-derived vesicles that participate in intercellular communication, delivering their cargo of molecules to specific cells. Exosomes are involved in several physiological and pathological processes including oncogenesis, immunomodulation, angiogenesis, and metastasis. The current study analyzed the expression of PDCD4 and miR-21 in resected OSC specimens and in cells and exosomes from OSC peritoneal effusions. METHODS: PDCD4 was immunohistochemically examined in 14 normal ovaries, 14 serous cystadenoma (CA), and 14 OSC cases. Quantitative reverse transcriptase-polymerase chain reaction analysis of PDCD4 and miR-21 expression was performed in CA and OSC cases and in cells and exosomes obtained from 10 OSC and 10 nonneoplastic peritoneal effusions. miR-21 was also evaluated by in situ hybridization. RESULTS: Immunohistochemistry demonstrated a gradual PDCD4 loss from normal ovaries to CA and OSC specimens. Quantitative reverse transcriptase-polymerase chain reaction displayed higher PDCD4 messenger RNA levels in CA specimens compared with OSC cases and highlighted miR-21 overexpression in OSC specimens. In situ hybridization detected miR-21 only in OSC cells. This PDCD4 and miR-21 inverse expression was also noted in cells and exosomes from OSC peritoneal effusions compared with nonneoplastic effusions. CONCLUSIONS: PDCD4 and miR-21 are involved in OSC oncogenesis. The transfer of miR-21 by exosomes could promote oncogenic transformation in target cells distant from the primary tumor without direct colonization by cancer cells and could be used as a diagnostic tool. (C) 2014 American Cancer Society.
引用
收藏
页码:685 / 693
页数:9
相关论文
共 50 条
  • [21] EFFECTS OF INFLAMMATORY STIMULATION ON PROGRAMMED CELL DEATH 4 EXPRESSION AND INVASIVE ACTIVITY IN HUMAN COLORECTAL CARCINOMA CELLS
    Nakamura, Kazuki
    Sasaki, Sayaka
    Hatai, Mayuko
    Kagota, Satomi
    Shinozuka, Kazumasa
    Yoshikawa, Noriko
    ANTICANCER RESEARCH, 2014, 34 (10) : 6076 - 6076
  • [22] MicroRNA-16, Programmed Cell Death Protein-4 (PDCD-4) and Polycystic Ovarian Syndrome
    Zehra, Naseem
    Azhar, Arfa
    Rehman, Rehana
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2020, 30 (08): : 880 - 881
  • [23] Aldose reductase inhibition suppresses colon cancer cell viability by modulating microRNA-21 mediated programmed cell death 4 (PDCD4) expression
    Saxena, Ashish
    Shoeb, Mohammad
    Ramana, Kota V.
    Srivastava, Satish K.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (15) : 3311 - 3319
  • [24] Expression of membrane-type 1, 2, and 3 matrix metalloproteinases messenger RNA in ovarian carcinoma cells in serous effusions
    Davidson, B
    Goldberg, I
    Berner, A
    Nesland, JM
    Givant-Horwitz, V
    Byrne, M
    Risberg, B
    Kristensen, GB
    Tropé, CG
    Kopolovic, J
    Reich, R
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2001, 115 (04) : 517 - 524
  • [25] Interleukin-17 is associated with expression of programmed cell death 1 ligand 1 in ovarian carcinoma
    Aotsuka, Aeri
    Matsumoto, Yoko
    Arimoto, Takahide
    Kawata, Akira
    Ogishima, Juri
    Taguchi, Ayumi
    Tanikawa, Michihiro
    Sone, Kenbun
    Mori-Uchino, Mayuyo
    Tsuruga, Tetsushi
    Oda, Katsutoshi
    Kawana, Kei
    Osuga, Yutaka
    Fujii, Tomoyuki
    CANCER SCIENCE, 2019, 110 (10) : 3068 - 3078
  • [26] MicroRNA-21, induced by high glucose, modulates macrophage apoptosis via programmed cell death 4
    Shang, Yuan-Yuan
    Fang, Ning-Ning
    Wang, Feng
    Wang, Hui
    Wang, Zhi-Hao
    Tang, Meng-Xiong
    Peng, Jie
    Zhang, Yun
    Zhang, Wei
    Zhong, Ming
    MOLECULAR MEDICINE REPORTS, 2015, 12 (01) : 463 - 469
  • [27] Effect of microRNA-21 on the proliferation of human degenerated nucleus pulposus by targeting programmed cell death 4
    Chen, B.
    Huang, S. G.
    Ju, L.
    Li, M.
    Nie, F. F.
    Zhang, Y.
    Zhang, Y. H.
    Chen, X.
    Gao, F.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2016, 49 (06)
  • [28] Prognostic effect of programmed cell death ligand 1/programmed cell death 1 expression in cancer stem cells of human oral squamous cell carcinoma
    Todoroki, Keita
    Abe, Yushi
    Matsuo, Katsuhisa
    Nomura, Hidetoshi
    Kawahara, Akihiko
    Nakamura, Yoshiaki
    Nakamura, Moriyoshi
    Seki, Naoko
    Kusukawa, Jingo
    ONCOLOGY LETTERS, 2024, 27 (02)
  • [29] Knockdown of microRNA-21 Inhibits Proliferation and Increases Cell Death by Targeting Programmed Cell Death 4 (PDCD4) in Pancreatic Ductal Adenocarcinoma
    Imran Bhatti
    Andrew Lee
    Victoria James
    Richard I. Hall
    Jonathan N. Lund
    Cristina Tufarelli
    Dileep N. Lobo
    Michael Larvin
    Journal of Gastrointestinal Surgery, 2011, 15 : 199 - 208
  • [30] Knockdown of microRNA-21 Inhibits Proliferation and Increases Cell Death by Targeting Programmed Cell Death 4 (PDCD4) in Pancreatic Ductal Adenocarcinoma
    Bhatti, Imran
    Lee, Andrew
    James, Victoria
    Hall, Richard I.
    Lund, Jonathan N.
    Tufarelli, Cristina
    Lobo, Dileep N.
    Larvin, Michael
    JOURNAL OF GASTROINTESTINAL SURGERY, 2011, 15 (01) : 199 - 208